Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Surgery Partners, Inc. (SGRY) Tops Q4 EPS by 7c
March 1, 2023 7:44 AM ESTSurgery Partners, Inc. (NASDAQ: SGRY) reported Q4 EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $707.1 million versus the consensus estimate of $688.06 million.
GUIDANCE:
Surgery Partners, Inc. sees Q1 2023 revenue of greater than $2.75 billion, versus... More
